BIOTIE THERAPIES CORP. STOCK EXCHANGE ANNOUNCEMENT 15 March 2010 at 1 p.m. Biotie's Annual Report 2009 and Corporate Governance Statement have been published Biotie Therapies Corp.'s Annual Report 2009 and Corporate Governance Statement have been published as attached to this stock exchange release and on the company website at www.biotie.com. The Annual Report including the Financial Statements and the report from the Board of Directors has been published in Finnish and English. The printed version of the Annual Report can be ordered at http://www.biotie.com/In_English/Investors/Financial_Information/Annual_Reports_ 2004-2009 or from the company, telephone +358 2 274 8900, e-mail virve.nurmi@biotie.com or address Tykistökatu 6, 20520 Turku, Finland. Turku, March 15, 2010 Biotie Therapies Corp. Timo Veromaa President and CEO For further information, please contact: Virve Nurmi, Investor Relations Manager tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com <mailto:virve.nurmi@biotie.com> Distribution: NASDAQ OMX Helsinki Ltd Main Media Biotie Therapies Corp. Biotie is a drug discovery and development company focused on central nervous system and inflammatory diseases. It has a broad range of innovative small molecule and biological drug candidates at different stages of clinical and pre-clinical development. Biotie's products address diseases with high unmet medical need and significant market potential, including addiction and psychotic disorders, rheumatoid arthritis, psoriasis and chronic obstructive pulmonary disease (COPD). The most advanced product, nalmefene for alcohol dependence, is currently in phase III clinical development by licensing partner H. Lundbeck A/S. The commercial value of the pipeline has been demonstrated through existing alliances with top-tier global pharmaceutical companies such as Lundbeck, Roche and Pfizer. Biotie has operations in Turku, Finland and Radebeul, Germany. Biotie shares are listed on NASDAQ OMX Helsinki Ltd. For more information, please refer to www.biotie.com [HUG#1393883]
Biotie's Annual Report 2009 and Corporate Governance Statement have been published
| Source: Biotie Therapies